SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending amid discussions around earnings, a new $3 billion AI infrastructure deal with Meta, and capacity constraints limiting even larger deals. The community is weighing strong revenue growth against a slight miss on estimates and a potential share dilution. Bullish sentiment remains due to the company's partnerships with major tech players and expansion plans.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending despite a double beat on earnings, driven by concerns over a slight cut to full-year revenue guidance due to data center delays. The community is debating whether the sell-off is an overreaction and a buying opportunity, highlighting the company's massive backlog and key partnerships in the AI space. Some investors are expressing concerns about the company's debt and reliance on third-party infrastructure, while others point to strong long-term growth potential and a potential overvaluation within the AI sector.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is trending as the community rallies around the coin, emphasizing its strong team and potential for significant gains. Recent sponsorships and real-world partnerships are being highlighted, alongside the coin's meme-friendly nature. The community is actively encouraging others to join and 'SLAP' the bears, fostering a bullish sentiment.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending amid discussions about its valuation, growth prospects, and potential reactions to upcoming earnings. The stock's volatility and recent price movements have traders debating support levels and possible short squeezes, while analysts weigh in with price target adjustments. Chatter also mentions an SEC probe impacting investor sentiment.

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

enGene Holdings Inc

ENGN is trending as traders discuss its potential for a short squeeze, citing a high cost to borrow and a low float. The stock's recent volatility and past runs are fueling speculation of another surge, with some highlighting analyst price targets in the $20-$30 range. Community members are actively monitoring order sizes and consolidation patterns, anticipating a breakout.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as investors discuss the company's recent earnings and acquisition of Ask Sage, a generative AI platform. Community members are weighing in on potential support levels, expressing both optimism for long-term growth and concerns about short-term market volatility. The focus remains on the potential for future government contracts and the impact of the Ask Sage acquisition on BigBear.ai's position in the AI and national security sectors.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending amid community excitement for upcoming catalysts, including presentations at the Skin Disease symposium and an FDA Type B meeting in December, which could pave the way for BLA approval.  Investors are closely watching for developments related to its lead drug, sonelokimab, and its potential in treating various inflammatory conditions. Discussions also revolve around major shareholders increasing their positions, signaling confidence in the company's future.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as investors digest news of SoftBank selling its stake, prompting debate about the AI bubble and its impact on the chipmaker. While some fear a potential downturn, others see this as a buying opportunity, emphasizing NVIDIA's strong fundamentals and future growth potential in AI, especially with earnings on deck next week.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors discuss recent delivery numbers and their impact on the stock's valuation, with some pointing to potential manipulation and short selling affecting the price. The community is debating NIO's long-term potential, particularly around its battery swap technology, while comparing it to competitors like Xpeng and Tesla. Broader discussions include profitability forecasts, institutional investment trends, and expansion into European markets.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is trending due to recent Injective network upgrades and community excitement around its potential. The community highlights the meme coin's strong performance against INJ, burned liquidity, active community, and successful NFTs. Discussions also focus on the potential impact of upcoming ETFs and institutional investment in the Injective ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Quoin Pharmaceuticals (QNRX) jumped as much as 39% on Tuesday after the company announced that the target loading concentrations for its two topical Rapamycin delivery technologies have been successfully achieved.A Rapamycin loading concentration of 4% w/w has been achieved for Quoin’s topical formulation, while an even higher concentration of 5% w/w has been formulated in a dermal patch system, the company said.Quoin is now looking to move forward with the manufacture of clinical trial batches from at least one of the delivery technologies this quarter. The company is targeting the commencement of clinical testing in the first half of 2026. &nbsp;Get updates to this developing story directly on Stocktwits.

Rising stock market chart on a trading board background.

QNRX Stock Soared A Whopping 39% Today: What’s Driving The Relentless Rally? 

A rapamycin loading concentration of 4% w/w has been achieved for Quoin’s topical formulation, while an even higher concentration of 5% w/w has been formulated in a dermal patch system, the company said.

Equity

Frame 485.png

Get the daily email that keeps you tuned in and makes markets fun again.

Frame 484.png

The most relevant Indian markets intel delivered to you everyday.

cryptotwits - 800x800.png

Get the daily crypto email you’ll actually love to read. It's value-packed, data-driven, and seasoned with wit.

Frame 479.png

The best trade ideas and analysis from the Stocktwits community. Delivered daily by 8 pm ET.

Frame 486.png

For serious investors with a serious sense of humor.

Frame 487.png

High Relative Strength, Low Social Following

QNRX Stock Soared A Whopping 39% Today: What’s Driving The Relentless Rally?

Latest News